BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
BHVN
Delisted
BHVN was delisted on the 3rd of October, 2022.
197 hedge funds and large institutions have $2.01B invested in Biohaven Pharmaceutical Holding Company Ltd. in 2019 Q2 according to their latest regulatory filings, with 64 funds opening new positions, 84 increasing their positions, 38 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
2% more capital invested
Capital invested by funds: $1.98B → $2.01B (+$30.1M)
8% less funds holding in top 10
Funds holding in top 10: 12 → 11 (-1)
Holders
197
Holding in Top 10
11
Calls
$162M
Puts
$60.6M
Top Buyers
| 1 | +$61M | |
| 2 | +$47.8M | |
| 3 | +$38.8M | |
| 4 |
TAL
TIG Advisors LLC
New York
|
+$33.2M |
| 5 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
+$28.5M |
Top Sellers
| 1 | -$64.4M | |
| 2 | -$37.5M | |
| 3 | -$36.4M | |
| 4 |
VC
Vivo Capital
Palo Alto,
California
|
-$26M |
| 5 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$18.6M |